Skip to main content
. 2026 Feb 26;17:1741741. doi: 10.3389/fphar.2026.1741741

FIGURE 7.

Diagram illustrating Engeletin inhibiting apoptosis and autophagy dysregulation by activating phosphorylated AMPK, which blocks the Doxorubicin-induced pathway that leads to oxidative stress, mitochondrial damage, and increased inflammatory markers IL-6, IL-1β, and TNF-α.

Revealing the mechanistic pathways underlying the cardioprotective effects of ENG against DOX-induced cardiotoxicity.